propylthiouracil and Eyelid-Diseases

propylthiouracil has been researched along with Eyelid-Diseases* in 2 studies

Other Studies

2 other study(ies) available for propylthiouracil and Eyelid-Diseases

ArticleYear
Atypical propylthiouracil-induced ANCA-positive vasculitis: report of a case with unusual clinical and histopathologic findings.
    Dermatology online journal, 2015, Aug-15, Volume: 21, Issue:8

    The side effects of propylthiouracil, including cytopenia and vasculitis, are well established.  We present an interesting case in which cytopenia and cutaneous vasculopathy occurred concomitantly in a critically ill patient.  The patient was initially treated for suspected infection until dermatologic and rheumatologic workup revealed ANCA-positivity and vasculopathy on histopathology, most consistent with an atypical presentation of ANCA-positive vasculitis.  Upon initiation of immunosuppressive therapy, the patient's condition rapidly improved emphasizing the importance of early recognition of this condition.

    Topics: Adult; Anorexia; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antithyroid Agents; Blister; Eyelid Diseases; Fatigue; Female; Graves Disease; Hemorrhage; Humans; Immunosuppressive Agents; Methylprednisolone; Pancytopenia; Pharyngitis; Prednisone; Propylthiouracil; Respiratory Insufficiency

2015
Eyelash loss associated with hyperthyroidism.
    Ophthalmic plastic and reconstructive surgery, 2002, Volume: 18, Issue:3

    To describe a patient with eyelash loss as the presenting feature of hyperthyroidism.. Case report.. A 19-year-old woman presented with right upper eyelid eyelash loss. Thyroid function studies confirmed hyperthyroidism. She subsequently lost further eyelashes and a patch of scalp hair. Once the hyperthyroidism was treated, the eyelashes and scalp hair regrew.. Eyelash loss may be an early sign of the hyperthyroid state.

    Topics: Adult; Antithyroid Agents; Eyelashes; Eyelid Diseases; Female; Hair Diseases; Humans; Hyperthyroidism; Propylthiouracil

2002